Additional assessment of the cellular immune response (detection of interferon-gamma, including the determination of pathogen-responsive T-cell activity) confirmed post-vaccination and post-COVID-19 immunization at the cellular level in all subjects. The gene discussed is IFNG; the disease is COVID-19.